Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.

Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Teraoka SN, Diep TA, Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, Bernstein JL; Women's Environment, Cancer, and Radiation Epidemiology Study Collaborative Group.

Cancer Res. 2008 Aug 15;68(16):6486-91. doi: 10.1158/0008-5472.CAN-08-0134.

2.

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

Bernstein JL, Haile RW, Stovall M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, Gatti RA, Concannon P; WECARE Study Collaborative Group.

J Natl Cancer Inst. 2010 Apr 7;102(7):475-83. doi: 10.1093/jnci/djq055. Epub 2010 Mar 19.

3.

Rare variants in the ATM gene and risk of breast cancer.

Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB, Terry MB, Daly MJ, Buys SM, Southey MC, Andrulis I, John EM; BCFR; kConFab, Khanna KK, Hopper JL, Oefner PJ, Lakhani S, Chenevix-Trench G.

Breast Cancer Res. 2011 Jul 25;13(4):R73. doi: 10.1186/bcr2919.

4.

Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.

Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P.

Hum Mutat. 2006 Nov;27(11):1122-8.

PMID:
16958054
5.

The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

Broeks A, Braaf LM, Huseinovic A, Schmidt MK, Russell NS, van Leeuwen FE, Hogervorst FB, Van 't Veer LJ.

Breast Cancer Res Treat. 2008 Jan;107(2):243-8. Epub 2007 Mar 28.

6.

Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.

Hirsch AE, Atencio DP, Rosenstein BS.

Breast Cancer Res Treat. 2008 Jan;107(1):139-44. Epub 2007 Feb 27.

PMID:
17333338
7.

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.

Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D; Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR, Rahman N.

Nat Genet. 2006 Aug;38(8):873-5. Epub 2006 Jul 9.

PMID:
16832357
8.

The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.

Stredrick DL, Garcia-Closas M, Pineda MA, Bhatti P, Alexander BH, Doody MM, Lissowska J, Peplonska B, Brinton LA, Chanock SJ, Struewing JP, Sigurdson AJ.

Hum Mutat. 2006 Jun;27(6):538-44.

9.

Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, Lesueur F, Byrnes GB, Chuang SC, Forey N, Feuchtinger C, Gioia L, Hall J, Hashibe M, Herte B, McKay-Chopin S, Thomas A, Vallée MP, Voegele C, Webb PM, Whiteman DC; Australian Cancer Study; Breast Cancer Family Registries (BCFR); Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab), Sangrajrang S, Hopper JL, Southey MC, Andrulis IL, John EM, Chenevix-Trench G.

Am J Hum Genet. 2009 Oct;85(4):427-46. doi: 10.1016/j.ajhg.2009.08.018. Epub 2009 Sep 24.

10.

Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.

Olsen JH, Hahnemann JM, Børresen-Dale AL, Tretli S, Kleinerman R, Sankila R, Hammarström L, Robsahm TE, Kääriäinen H, Bregård A, Brøndum-Nielsen K, Yuen J, Tucker M.

Br J Cancer. 2005 Jul 25;93(2):260-5.

11.

Two ATM variants and breast cancer risk.

Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, Goldgar D, Hopper JL, Easton D, Chenevix-Trench G; KConFab Investigators.

Hum Mutat. 2005 Jun;25(6):594-5.

PMID:
15880680
12.

Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.

Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):821-5.

13.

Contribution of mutations in ATM to breast cancer development in the Czech population.

Soukupova J, Dundr P, Kleibl Z, Pohlreich P.

Oncol Rep. 2008 Jun;19(6):1505-10.

PMID:
18497957
14.

ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.

Paglia LL, Laugé A, Weber J, Champ J, Cavaciuti E, Russo A, Viovy JL, Stoppa-Lyonnet D.

Breast Cancer Res Treat. 2010 Jan;119(2):443-52. doi: 10.1007/s10549-009-0396-z. Epub 2009 Apr 29.

PMID:
19404735
15.

ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.

Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum SL, Olsen JH, Anton-Culver H, Boice JD, Rosenstein BS, Børresen-Dale AL, Gatti RA, Concannon P, Haile RW; WECARE Study Collaborative Group.

Br J Cancer. 2003 Oct 20;89(8):1513-6.

16.

The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.

Hall J.

Cancer Lett. 2005 Sep 28;227(2):105-14. Epub 2005 Jan 8. Review.

PMID:
16112413
17.

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

Broeks A, Braaf LM, Huseinovic A, Nooijen A, Urbanus J, Hogervorst FB, Schmidt MK, Klijn JG, Russell NS, Van Leeuwen FE, Van 't Veer LJ.

Breast Cancer Res. 2007;9(2):R26.

18.

Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.

Fletcher O, Johnson N, dos Santos Silva I, Orr N, Ashworth A, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Burwinkel B, Bartram CR, Meindl A, Schmutzler RK, Cox A, Brock I, Elliott G, Reed MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Schürmann P, Waltes R, Bremer M, Dörk T, Devilee P, van Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Humphreys K, Liu J, Ahmed S, Dunning AM, Maranian M, Pharoah PD, Chenevix-Trench G; kConFab Investigators; AOCS Group, Beesley J, Bogdanova NV, Antonenkova NN, Zalutsky IV, Anton-Culver H, Ziogas A, Brauch H, Ko YD, Hamann U; GENICA Consortium, Fasching PA, Strick R, Ekici AB, Beckmann MW, Giles GG, Severi G, Baglietto L, English DR, Milne RL, Benítez J, Arias JI, Pita G, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo KY, Noh DY, Mannermaa A, Kataja V, Kosma VM, García-Closas M, Chanock S, Lissowska J, Brinton LA, Chang-Claude J, Wang-Gohrke S, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Margolin S, Lindblom A, Humphreys MK, Morrison J, Platte R, Easton DF, Peto J; Breast Cancer Association Consortium.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2143-51. doi: 10.1158/1055-9965.EPI-10-0374.

19.

Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.

Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice JD Jr, Lynch CF, Mellemkjaer L, Malone KE, Liang X; Wecare Study Collaborative Group, Haile RW, Concannon P, Bernstein JL.

Hum Mutat. 2012 Jan;33(1):158-64. doi: 10.1002/humu.21604. Epub 2011 Sep 29.

20.

A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.

Bogdanova N, Cybulski C, Bermisheva M, Datsyuk I, Yamini P, Hillemanns P, Antonenkova NN, Khusnutdinova E, Lubinski J, Dörk T.

Breast Cancer Res Treat. 2009 Nov;118(1):207-11. doi: 10.1007/s10549-008-0189-9. Epub 2008 Sep 21.

PMID:
18807267
Items per page

Supplemental Content

Write to the Help Desk